COPD频繁急性加重表型的无假设统计验证
本研究基于法国EXACO队列中COPD患者的前瞻性急性加重数据,采用KmL纵向聚类与ROC曲线分析无先验假设地识别加重模式。结果识别出两个聚类,年均加重次数分别为2.89次和0.71次,最佳区分阈值为每年2次中重度加重。频繁加重者气流受限、症状及健康相关生活质量损害更重,并衍生出简易临床评分辅助识别高危患者。
要点
- 无假设统计方法确认COPD频繁加重表型真实存在且具临床相关性
- 区分频繁加重聚类的最佳阈值为每年2次中重度加重
- 频繁加重者气流受限、症状和生活质量损害更严重
核心结论
- 统计分析确认了COPD频繁加重者亚组的存在及其临床相关性,并支持当前用于定义该表型的阈值。
研究设计与样本
- 基于法国EXACO队列中COPD患者的前瞻性记录急性加重数据进行分析。
- 采用KmL方法对纵向数据进行聚类,并用ROC曲线分析确定最佳阈值。
- 进行单因素和多因素分析研究不同聚类相关的特征。
主要发现
- 基于随时间变化的加重频率识别出两个聚类,第一聚类(n=348)年均加重2.89次,第二聚类(n=116)年均0.71次。
- 区分两聚类的最佳阈值为每年2次中重度加重。
- 频繁加重者气流受限、症状及健康相关生活质量损害更严重。
- 衍生出一个简易临床评分以帮助识别有加重风险的患者。
关键数值与推荐
- 频繁加重聚类年均加重2.89次(n=348),非频繁加重聚类年均0.71次(n=116)。
- 区分频繁与非频繁加重聚类的最佳阈值为每年2次中重度加重。
临床怎么用
- 临床可沿用每年2次中重度加重作为识别COPD频繁加重表型的阈值。
- 对频繁加重者应关注其更严重的气流受限、症状及生活质量损害。
- 可参考衍生出的简易临床评分辅助识别有加重风险的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The COPD "frequent exacerbator" phenotype is usually defined by at least two treated exacerbations per year and is associated with a huge impact on patient health. However, existence of this phenotype and corresponding thresholds still need to be formally confirmed by statistical methods analyzing exacerbation profiles with no specific a priori hypothesis. The aim of this study was to confirm the existence of the frequent exacerbator phenotype with an innovative unbiased statistical analysis of prospectively recorded exacerbations. METHODS: Data from patients with COPD from the French cohort in Exacerbations of COPD Patients (EXACO) were analyzed using the KmL method designed to cluster longitudinal data and receiver operating characteristic (ROC) curve analysis to determine the best threshold to allocate patients to identified clusters. Univariate and multivariate analyses were performed to study characteristics associated with different clusters. RESULTS: Two clusters of patients were identified based on exacerbation frequency over time, with 2.89 exacerbations per year on average in the first cluster (n = 348) and 0.71 on average in the second cluster (n = 116). The best threshold to distinguish these clusters was two moderate to severe exacerbations per year. Frequent exacerbators had more airflow limitation, symptoms, and health-related quality of life impairment. A simple clinical score was derived to help identify patients at risk of exacerbations. CONCLUSIONS: These analyses confirmed the existence and clinical relevance of a frequent exacerbator subgroup of patients with COPD and the currently used threshold to define this phenotype.
引用
- Le Rouzic O, Roche N, Cortot AB, et al. Defining the "Frequent Exacerbator" Phenotype in COPD: A Hypothesis-Free Approach. Chest. 2017. PMID: 29054347. doi:10.1016/j.chest.2017.10.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。